Glenmede Trust Co. NA trimmed its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 27.6% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,235 shares of the company’s stock after selling 3,520 shares during the quarter. Glenmede Trust […]

Glenmede Trust Co. NA lessened its stake in shares of Starbucks Corporation (NASDAQ:SBUX – Free Report) by 6.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 275,423 shares of the coffee company’s stock after selling 20,336 shares during the quarter. Glenmede Trust […]